we have evaluated the chemotherapeutic potential of 2,4-dihydroxyphenylalanine , a targeted prodrug that can be hydroxylated by tyrosinase ( monophenol monooxygenase , ec 1.14.18.1 ) within melanoma cells to form the cellular toxin 2,4,5-trihydroxyphenylalanine ( 6-hydroxydopa ) .
C0012524
tyrosinase
C0041484
monophenol